Skip to main content

What the FDA labels say about taking them together

Nilutamide and phenytoin

Nilutamide's FDA label of June 26, 2026 names phenytoin in its drug interactions section; the phenytoin labels PlainMeds reads (2) do not name nilutamide. The nilutamide label: “Consequently, drugs with a low therapeutic margin, such as vitamin K antagonists, phenytoin, and theophylline, could have a delayed elimination and increases in their serum half-life leading to a toxic level.”

Check it at the source: the nilutamide FDA label on DailyMed (effective June 26, 2026, ANI Pharmaceuticals, Inc.); the phenytoin FDA label on DailyMed (effective October 15, 2024, Mylan Pharmaceuticals Inc.).

What does the nilutamide label say about phenytoin?

Nilutamide label, drug interactions

Consequently, drugs with a low therapeutic margin, such as vitamin K antagonists, phenytoin, and theophylline, could have a delayed elimination and increases in their serum half-life leading to a toxic level.

Source: FDA drug label (Nilutamide), ANDA207631 (Ani Pharms), as published by ANI Pharmaceuticals, Inc., effective June 26, 2026 (SPL set d5740b8f-fbb3-4023-9133-9e359a9ab980), via openFDA; the full label on DailyMed

What does the phenytoin label say about nilutamide?

Phenytoin's label (effective October 15, 2024) and its 1 other brand-application label do not name nilutamide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenytek), Mylan Pharmaceuticals Inc., effective October 15, 2024 (SPL set 0f94c791-8b07-4b41-927e-c9f28bec5f60), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

1Nilutamide generic labelers
29Phenytoin generic labelers
NilutamidePhenytoin
Labeled forProstate cancerSeizures and epilepsy
Boxed warningYesNo
Pharmacy cost (NADAC)n/a$0.145 per capsule 100 mg capsule
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?